{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T10:42:40Z","timestamp":1794134560076,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Startup Fund for Scientific Research, Fujian Medical University","award":["2023QH2050"],"award-info":[{"award-number":["2023QH2050"]}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian province","award":["2021Y9196"],"award-info":[{"award-number":["2021Y9196"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473376"],"award-info":[{"award-number":["82473376"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province, China","award":["2021ZQNZD010"],"award-info":[{"award-number":["2021ZQNZD010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recurrence and metastasis remain the primary causes of treatment failure in nasopharyngeal carcinoma (NPC). This study aims to explore the functional role and regulatory mechanisms of peroxidasin (PXDN) in NPC progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Weighted gene co-expression network analysis was performed to screen the module most relevant to the malignant progression of NPC from our internal cohort (Fujian cohort 1,\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009192), from which the PXDN was identified as the key molecule. Clinical significance of PXDN was assessed in the GEO database and NPC tissue microarrays from Fujian cohort 2 (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009103). Functional experiments were used to determine the biological role of PXDN in NPC. Methylated RNA immunoprecipitation sequencing was used to identify PXDN N6-methyladenosine (m\n                      <jats:sup>6<\/jats:sup>\n                      A) modification site, and verified by a dual-luciferase reporter gene assay. RNA immunoprecipitation, RNA stability assay, and RNA pull-down assay were used to verify the relationship between PXDN and YTHDF1. The CRISPR\/Cas9 system was used to disrupt the m\u2076A motif in the PXDN gene to further validate its role. Next, transcriptome, proteomic analysis, and immunoprecipitation assay were conducted to assess downstream targets.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PXDN was highly expressed in NPC and associated with poor prognosis. Suppression of PXDN drastically reduced proliferation, migration, invasion, and resistance to chemoradiation in vitro, concomitant with attenuated epithelial-mesenchymal transition. Knockdown of PXDN remarkably suppressed NPC tumorigenicity and liver metastasis in vivo. Mechanistically, PXDN promotes aggressiveness by extracellular matrix remodelling to activate the ITGB1-PI3K-AKT pathway. The aberrant expression of PXDN is governed by an m\n                      <jats:sup>6<\/jats:sup>\n                      A-based regulatory axis, wherein YTHDF1 recognizes WTAP-mediated PXDN m\n                      <jats:sup>6<\/jats:sup>\n                      A methylation to enhance its RNA stability and translation. Targeted specific demethylation of PXDN m\n                      <jats:sup>6<\/jats:sup>\n                      A by CRISPR\/Cas9 system significantly decreased the expression of PXDN.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We reveal the crucial role of PXDN in driving NPC malignancy and the regulatory role of m\n                      <jats:sup>6<\/jats:sup>\n                      A methylation modification. Targeting PXDN expression or activity could be used to effectively control NPC progression.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03609-y","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T12:46:34Z","timestamp":1766061994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["PXDN regulated by WTAP\/YTHDF1-mediated m6A modification activates PI3K\/AKT signaling pathway through extracellular matrix remodeling to promote progression in nasopharyngeal carcinoma"],"prefix":"10.1186","volume":"45","author":[{"given":"Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanzun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wankai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"issue":"3","key":"3609_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10555-024-10176-9","volume":"43","author":"ZY Su","year":"2024","unstructured":"Su ZY, Siak PY, Lwin YY, Cheah SC. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook. Cancer Metastasis Rev. 2024;43(3):919\u201339.","journal-title":"Cancer Metastasis Rev"},{"issue":"10192","key":"3609_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64\u201380.","journal-title":"Lancet"},{"key":"3609_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.oraloncology.2017.11.022","volume":"76","author":"T Xu","year":"2018","unstructured":"Xu T, Zhou X, Shen C, Hu C. Suggestions for surveillance and radiation strategy in nasopharyngeal carcinoma treated with IMRT: based on hazard-rate and patterns of recurrence. Oral Oncol. 2018;76:61\u20137.","journal-title":"Oral Oncol"},{"issue":"11","key":"3609_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","volume":"18","author":"KCW Wong","year":"2021","unstructured":"Wong KCW, Hui EP, Lo KW, Lam WKJ, Johnson D, Li L, et al. Nasopharyngeal carcinoma: an evolving paradigm. Nat Rev Clin Oncol. 2021;18(11):679\u201395.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"3609_CR5","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamaoncol.2020.1808","volume":"6","author":"R You","year":"2020","unstructured":"You R, Liu YP, Huang PY, Zou X, Sun R, He YX, et al. Efficacy and safety of locoregional radiotherapy with chemotherapy vs chemotherapy alone in de Novo metastatic nasopharyngeal carcinoma: A multicenter phase 3 randomized clinical trial. JAMA Oncol. 2020;6(9):1345\u201352.","journal-title":"JAMA Oncol"},{"issue":"3","key":"3609_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT transition States during tumor progression and metastasis. Trends Cell Biol. 2019;29(3):212\u201326.","journal-title":"Trends Cell Biol"},{"issue":"8","key":"3609_CR7","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.7150\/thno.24003","volume":"8","author":"XK Qi","year":"2018","unstructured":"Qi XK, Han HQ, Zhang HJ, Xu M, Li L, Chen L, et al. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma. Theranostics. 2018;8(8):2202\u201316.","journal-title":"Theranostics"},{"issue":"2","key":"3609_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3609_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.gene.2018.01.011","volume":"646","author":"BN Sitole","year":"2018","unstructured":"Sitole BN, Mavri-Damelin D. Peroxidasin is regulated by the epithelial-mesenchymal transition master transcription factor Snai1. Gene. 2018;646:195\u2013202.","journal-title":"Gene"},{"issue":"5","key":"3609_CR10","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1042\/BST20230018","volume":"51","author":"K Wyllie","year":"2023","unstructured":"Wyllie K, Panagopoulos V, Cox TR. The role of Peroxidasin in solid cancer progression. Biochem Soc Trans. 2023;51(5):1881\u201395.","journal-title":"Biochem Soc Trans"},{"issue":"15","key":"3609_CR11","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.3390\/ijms21155416","volume":"21","author":"M Kurihara-Shimomura","year":"2020","unstructured":"Kurihara-Shimomura M, Sasahira T, Shimomura H, Kirita T. Peroxidan plays a tumor-promoting role in oral squamous cell carcinoma. Int J Mol Sci. 2020;21(15):5416.","journal-title":"Int J Mol Sci"},{"key":"3609_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.anndiagpath.2018.03.002","volume":"34","author":"YZ Zheng","year":"2018","unstructured":"Zheng YZ, Liang L. High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer. Ann Diagn Pathol. 2018;34:161\u20135.","journal-title":"Ann Diagn Pathol"},{"key":"3609_CR13","doi-asserted-by":"publisher","first-page":"1463011","DOI":"10.3389\/fonc.2024.1463011","volume":"14","author":"YC Li","year":"2024","unstructured":"Li YC, Xiao YH, Chen FX, Xiao SY, Lin JM, Cai ST, et al. PXDN as a pan-cancer biomarker and promotes tumor progress via immune Inhibition in nasopharyngeal carcinoma. Front Oncol. 2024;14:1463011.","journal-title":"Front Oncol"},{"issue":"7","key":"3609_CR14","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/s41416-024-02579-w","volume":"130","author":"W Lin","year":"2024","unstructured":"Lin W, Chen X, Huang Z, Ding Q, Yang H, Li Y, et al. Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma. Br J Cancer. 2024;130(7):1176\u201386.","journal-title":"Br J Cancer"},{"key":"3609_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"10","key":"3609_CR16","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1093\/nar\/gkw104","volume":"44","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44(10):e91.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"3609_CR17","doi-asserted-by":"publisher","first-page":"R536","DOI":"10.1016\/j.cub.2021.01.038","volume":"31","author":"MR Chastney","year":"2021","unstructured":"Chastney MR, Conway JRW, Ivaska J. Integrin adhesion complexes. Curr Biol. 2021;31(10):R536\u201342.","journal-title":"Curr Biol"},{"issue":"2","key":"3609_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrm.2016.140","volume":"18","author":"BR Sabari","year":"2017","unstructured":"Sabari BR, Zhang D, Allis CD, Zhao Y. Metabolic regulation of gene expression through histone acylations. Nat Rev Mol Cell Biol. 2017;18(2):90\u2013101.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7397","key":"3609_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485(7397):201\u20136.","journal-title":"Nature"},{"key":"3609_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.freeradbiomed.2022.02.026","volume":"182","author":"G Cheng","year":"2022","unstructured":"Cheng G, Shi R. Mammalian Peroxidasin (PXDN): from physiology to pathology. Free Radic Biol Med. 2022;182:100\u20137.","journal-title":"Free Radic Biol Med"},{"issue":"15","key":"3609_CR21","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.1158\/0008-5472.CAN-11-0568","volume":"71","author":"SJ Pitteri","year":"2011","unstructured":"Pitteri SJ, Kelly-Spratt KS, Gurley KE, Kennedy J, Buson TB, Chin A, et al. Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression. Cancer Res. 2011;71(15):5090\u2013100.","journal-title":"Cancer Res"},{"key":"3609_CR22","doi-asserted-by":"publisher","first-page":"102090","DOI":"10.1016\/j.redox.2021.102090","volume":"46","author":"M Paumann-Page","year":"2021","unstructured":"Paumann-Page M, Kienzl NF, Motwani J, Bathish B, Paton LN, Magon NJ, et al. Peroxidasin protein expression and enzymatic activity in metastatic melanoma cell lines are associated with invasive potential. Redox Biol. 2021;46:102090.","journal-title":"Redox Biol"},{"issue":"27","key":"3609_CR23","doi-asserted-by":"publisher","first-page":"41186","DOI":"10.18632\/oncotarget.9227","volume":"7","author":"A Jayachandran","year":"2016","unstructured":"Jayachandran A, Prithviraj P, Lo PH, Walkiewicz M, Anaka M, Woods BL, et al. Identifying and targeting determinants of melanoma cellular invasion. Oncotarget. 2016;7(27):41186\u2013202.","journal-title":"Oncotarget"},{"issue":"21","key":"3609_CR24","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.3748\/wjg.v19.i21.3249","volume":"19","author":"S Supiot","year":"2013","unstructured":"Supiot S, Gouraud W, Campion L, Jez\u00e9quel P, Buecher B, Charrier J, et al. Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility study. World J Gastroenterol. 2013;19(21):3249\u201354.","journal-title":"World J Gastroenterol"},{"key":"3609_CR25","doi-asserted-by":"publisher","first-page":"110909","DOI":"10.1016\/j.biopha.2020.110909","volume":"133","author":"G Babaei","year":"2021","unstructured":"Babaei G, Aziz SG, Jaghi NZZ. EMT, cancer stem cells and autophagy; the three main axes of metastasis. Biomed Pharmacother. 2021;133:110909.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"3609_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.31083\/j.fbl2709277","volume":"27","author":"A Gilbert","year":"2022","unstructured":"Gilbert A, Payet V, Bernay B, Chartier-Garcia E, Testard I, Cand\u00e9ias SM, et al. Label-free direct mass spectrometry analysis of the bystander effects induced in chondrocytes by chondrosarcoma cells irradiated with X-rays and carbon ions. Front Biosci (Landmark Ed). 2022;27(9):277.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"22","key":"3609_CR27","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1158\/0008-5472.CAN-16-3521","volume":"77","author":"JT George","year":"2017","unstructured":"George JT, Jolly MK, Xu S, Somarelli JA, Levine H. Survival outcomes in cancer patients predicted by a partial EMT gene expression scoring metric. Cancer Res. 2017;77(22):6415\u201328.","journal-title":"Cancer Res"},{"issue":"1","key":"3609_CR28","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s42003-021-02499-y","volume":"4","author":"DR Bergman","year":"2021","unstructured":"Bergman DR, Karikomi MK, Yu M, Nie Q, MacLean AL. Modeling the effects of EMT-immune dynamics on carcinoma disease progression. Commun Biol. 2021;4(1):983.","journal-title":"Commun Biol"},{"issue":"4","key":"3609_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10911-021-09507-1","volume":"26","author":"AK Sigurdardottir","year":"2021","unstructured":"Sigurdardottir AK, Jonasdottir AS, Asbjarnarson A, Helgudottir HR, Gudjonsson T, Traustadottir GA. Peroxidasin enhances basal phenotype and inhibits branching morphogenesis in breast epithelial progenitor cell line D492. J Mammary Gland Biol Neoplasia. 2021;26(4):321\u201338.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"2","key":"3609_CR30","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.mcpro.2021.100185","volume":"21","author":"Q Wang","year":"2022","unstructured":"Wang Q, Karvelsson ST, Kotronoulas A, Gudjonsson T, Halldorsson S, Rolfsson O. Glutamine-fructose-6-phosphate transaminase 2 (GFPT2) is upregulated in breast epithelial-mesenchymal transition and responds to oxidative stress. Mol Cell Proteom. 2022;21(2):100185.","journal-title":"Mol Cell Proteom"},{"issue":"1","key":"3609_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","volume":"81","author":"W Xue","year":"2024","unstructured":"Xue W, Yang L, Chen C, Ashrafizadeh M, Tian Y, Sun R. Wnt\/\u03b2-catenin-driven EMT regulation in human cancers. Cell Mol Life Sci. 2024;81(1):79.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3609_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6(1):425.","journal-title":"Signal Transduct Target Ther"},{"key":"3609_CR33","doi-asserted-by":"publisher","first-page":"119601","DOI":"10.1016\/j.lfs.2021.119601","volume":"284","author":"O Kadioglu","year":"2021","unstructured":"Kadioglu O, Saeed MEM, Mahmoud N, Azawi S, Mrasek K, Liehr T, et al. Identification of novel drug resistance mechanisms by genomic and transcriptomic profiling of glioblastoma cells with mutation-activated EGFR. Life Sci. 2021;284:119601.","journal-title":"Life Sci"},{"issue":"728","key":"3609_CR34","doi-asserted-by":"publisher","first-page":"eadg3840","DOI":"10.1126\/scitranslmed.adg3840","volume":"16","author":"JJF Sleeboom","year":"2024","unstructured":"Sleeboom JJF, van Tienderen GS, Schenke-Layland K, van der Laan LJW, Khalil AA, Verstegen MMA. The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets. Sci Transl Med. 2024;16(728):eadg3840.","journal-title":"Sci Transl Med"},{"issue":"35","key":"3609_CR35","doi-asserted-by":"publisher","first-page":"21741","DOI":"10.1074\/jbc.M115.673996","volume":"290","author":"IA Ero-Tolliver","year":"2015","unstructured":"Ero-Tolliver IA, Hudson BG, Bhave G. The ancient Immunoglobulin domains of Peroxidasin are required to form sulfilimine cross-links in collagen IV. J Biol Chem. 2015;290(35):21741\u20138.","journal-title":"J Biol Chem"},{"key":"3609_CR36","doi-asserted-by":"publisher","first-page":"108443","DOI":"10.1016\/j.abb.2020.108443","volume":"689","author":"B Sevcnikar","year":"2020","unstructured":"Sevcnikar B, Schaffner I, Chuang CY, Gamon L, Paumann-Page M, Hofbauer S, et al. The leucine-rich repeat domain of human Peroxidasin 1 promotes binding to laminin in basement membranes. Arch Biochem Biophys. 2020;689:108443.","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"3609_CR37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110(6):673\u201387.","journal-title":"Cell"},{"key":"3609_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.redox.2018.08.005","volume":"19","author":"S Cui","year":"2018","unstructured":"Cui S, Lv X, Li W, Li Z, Liu H, Gao Y, et al. Folic acid modulates VPO1 DNA methylation levels and alleviates oxidative stress-induced apoptosis in vivo and in vitro. Redox Biol. 2018;19:81\u201391.","journal-title":"Redox Biol"},{"key":"3609_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.gene.2018.06.076","volume":"674","author":"KL Hanmer","year":"2018","unstructured":"Hanmer KL, Mavri-Damelin D. Peroxidasin is a novel target of the redox-sensitive transcription factor Nrf2. Gene. 2018;674:104\u201314.","journal-title":"Gene"},{"issue":"1","key":"3609_CR40","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1038\/s41467-019-11375-7","volume":"10","author":"BA Elliott","year":"2019","unstructured":"Elliott BA, Ho HT, Ranganathan SV, Vangaveti S, Ilkayeva O, Abou Assi H, et al. Modification of messenger RNA by 2\u2019-O-methylation regulates gene expression in vivo. Nat Commun. 2019;10(1):3401.","journal-title":"Nat Commun"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03609-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03609-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03609-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:23:28Z","timestamp":1781623408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03609-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3609"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03609-y","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical clearance for this investigation was obtained from the institutional review board of Fujian Cancer Hospital (K2022-084-01), with retrospective nature of the study rendering patient informed consent unnecessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}